AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
[ad_1]
The deal is AbbVie's latest attempt to expand its drug pipeline as its top-selling treatments, such as Humira, face generic competition.
[ad_2]
Source link
- Vast Data lands $118M to grow its data storage platform for AI workloads | TechCrunch
- EP rapporteur on Turkey visits philanthropist Kavala in prison
